Search results for "Diabetes"
GLP-1 agonist plus basal insulin beat other diabetes treatment regimens in meta-analysis
Patients on combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin had better HbA1c values, less weight gain, and similar hypoglycemia rates compared to patients on other type 2 diabetes treatment regimens, a new analysis of previous trials found.
https://immattersacp.org/weekly/archives/2014/09/23/2.htm
23 Sep 2014
Experts debate dilemmas in colorectal cancer screening
The latest ACP/Annals of Internal Medicine virtual forum discussed the controversy around colorectal cancer screening, clarified the rationale supporting the varying recommendations, and equipped physicians to make screening choices that best align with patients' clinical situations.
https://immattersacp.org/archives/2024/02/experts-debate-dilemmas-in-colorectal-cancer-screening.htm
1 Feb 2024
Task Force releases systematic review about diabetes screening
A systematic evidence review by the U.S. Preventive Services Task Force suggests that screening asymptomatic adults for elevated glucose levels could help delay progression to diabetes but has not been shown to improve mortality rates.
https://immattersacp.org/weekly/archives/2015/04/14/1.htm
14 Apr 2015
Lifestyle modification may outperform medications over time for diabetes prevention in at-risk adults, meta-analysis finds
The risk difference between lifestyle modification and medication studies was 4 cases per 100 person-years, and 25 people would need to be treated with lifestyle modification to prevent one diabetes case.
https://immattersacp.org/weekly/archives/2017/11/14/1.htm
14 Nov 2017
Screening detected unknown diabetes in one-fourth of elective surgery patients
Among elective surgery patients, nearly one-fourth (24%) were diagnosed with previously unknown diabetes or pre-diabetes based on blood tests conducted while they were fasting pre-operatively, researchers found.
https://immattersacp.org/weekly/archives/2012/08/14/5.htm
14 Aug 2012
Latest diabetes drugs have a learning curve
The onus is on internists to understand the newer classes of incretins such as sodium-glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors. They hold promise for better treatments, but they are new and not as well understood as older treatments.
https://immattersacp.org/archives/2015/10/diabetes.htm
1 Oct 2015
CGM decreased HbA1c levels, hypoglycemia in patients with type 2 diabetes
Two industry-supported studies of continuous glucose monitoring (CGM) found encouraging results in patients with type 2 diabetes, leading editorialists to call for broadened access to the technology in this population, particularly in primary care.
https://immattersacp.org/weekly/archives/2021/06/08/4.htm
8 Jun 2021
Points on providing gender-affirming care
There are simple things that physicians can do, regardless of their practice setting, to communicate to patients that they are safe in the clinical space.
https://immattersacp.org/archives/2024/02/points-on-providing-gender-affirming-care.htm
1 Feb 2024
Dapagliflozin reduced risk for hospitalization in CKD patients with or without diabetes
A post hoc analysis of an industry-funded trial found that dapagliflozin reduced overall risk of hospitalization as well as risk of hospitalization ending in death in patients with chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/12/06/3.htm
6 Dec 2022
Keep a close eye on the kidneys in diabetes
Screening and adherence to best prescribing practices offer two key ways to prevent or slow the progression of chronic kidney disease in patients with diabetes.
https://immattersacp.org/archives/2020/09/keep-a-close-eye-on-the-kidneys-in-diabetes.htm
1 Sep 2020